Physician profile
Sara Smith
NPI 1093126450
$1,106.38
in general payments reported to CMS, 2019-2025
18 companies · $396 in 2025
The $396 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $358 · 2022: $98.26 · 2023: $109 · 2024: $145 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $650.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $181.21 | 2024-2025 | Nuzyra |
| Smith+Nephew, INC. | $172.12 | 2022-2025 | Grafix, Grafix Pl, Collagenase Santyl |
| Abbvie INC. | $157.22 | 2021-2025 | |
| Novo Nordisk INC | $141.30 | 2021-2022 | |
| Veloxis Pharmaceuticals, INC. | $106.23 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $52.63 | 2021-2022 | |
| Endotronix, INC. | $44.33 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Innovation Technologies INC | $41.21 | 2024 | Irrisept |
| Integra Lifesciences Corporation | $34.74 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Lilly USA, LLC | $32.05 | 2021 | |
| Solventum Corporation | $25.24 | 2025 | Activ.A.C. |
| Reapplix INC. | $21.30 | 2025 | 3c Patch Kit - Box |
| Urgo Medical North America, LLC | $20.38 | 2025 | Urgoclean Ag |
| Ultragenyx Pharmaceutical INC. | $17.40 | 2021 | |
| Ardelyx, INC. | $17.35 | 2023 | Ibsrela |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bsn Medical INC | $14.64 | 2025 | |
| Cranial Technologies, INC | $13.91 | 2021 | |
| Amneal Pharmaceuticals LLC | $13.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.